Minerva Neurosciences NERV
NASDAQ NERV
$4.43 -0.26 (-5.54%)
At close: Sep 4, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Interest Coverage Ratio (2014)

Minerva Neurosciences' (NERV) quarterly Interest Coverage Ratio came in at 1.02 in Q1 2026, up 73.88% on a QoQ basis from 3.92 in Q4 2025.

Analysis

Minerva Neurosciences (NERV) Interest Coverage Ratio (2014) Analysis & Trends

Minerva Neurosciences (NERV) has 14 years of Interest Coverage Ratio data on file, last reported at 1.02 in Q1 2026.

  • Quarterly Interest Coverage Ratio changed N/A year-over-year to 1.02 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.71 (changed N/A YoY) and the FY2025 annual result came in at 0.15, up 33.38% from the prior year.
  • Interest Coverage Ratio rose to 1.02 in Q1 2026, from 3.92 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 0.05 in Q4 2024 to a low of 369.27 in Q2 2024.
  • A 5-year average of 52.66 and a median of 3.08 in 2023 frame the typical range for Interest Coverage Ratio.
  • Annual changes were most pronounced in 2022 — Interest Coverage Ratio surged 78.09% — and 2024, when it plunged 16419.07%.
  • Tracing NERV's Interest Coverage Ratio over 5 years: stood at 0.06 in 2022, then plunged by 31.6% to 0.07 in 2023, then jumped by 36.41% to 0.05 in 2024, then slumped by 8231.74% to 3.92 in 2025, then soared by 73.88% to 1.02 in 2026.
  • The last three Interest Coverage Ratio figures came in at 1.02 (Q1 2026), 3.92 (Q4 2025), and 0.05 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 Minerva Neurosciences 207.37 Mn 207.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 -10.22